Evidence map›Paper›PMID 39578272›Full record

ArticlePlant cell reports2024

Next-generation marker-free transplastomic plants: engineering the chloroplast genome without integration of marker genes in Solanum tuberosum (potato).

Alessandro Occhialini, Andrew C Reed, Stacee A Harbison, Megan J Sichterman, Aaron Baumann, Alexander C Pfotenhauer, Li Li, Gabriella King, Aaron G Vincent, Ashley D Wise-Mitchell and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Plant cell reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alessandro OcchialiniDepartment of Plant Sciences, University of Tennessee, 301 Ag & Natural Resources Bldg., 2431 Joe Johnson Drive, Knoxville, TN, 37996, USA.ORCID http://orcid.org/0000-0002-1162-798X
Andrew C ReedCenter for Agricultural Synthetic Biology (CASB), University of Tennessee, 2640 Morgan Circle Dr., Knoxville, TN, 37996, USA.
Stacee A HarbisonCenter for Agricultural Synthetic Biology (CASB), University of Tennessee, 2640 Morgan Circle Dr., Knoxville, TN, 37996, USA.
Megan J SichtermanCenter for Agricultural Synthetic Biology (CASB), University of Tennessee, 2640 Morgan Circle Dr., Knoxville, TN, 37996, USA.
Aaron BaumannCenter for Agricultural Synthetic Biology (CASB), University of Tennessee, 2640 Morgan Circle Dr., Knoxville, TN, 37996, USA.
Alexander C PfotenhauerCenter for Agricultural Synthetic Biology (CASB), University of Tennessee, 2640 Morgan Circle Dr., Knoxville, TN, 37996, USA.
Li LiCenter for Agricultural Synthetic Biology (CASB), University of Tennessee, 2640 Morgan Circle Dr., Knoxville, TN, 37996, USA.
Gabriella KingDepartment of Plant Sciences, University of Tennessee, 301 Ag & Natural Resources Bldg., 2431 Joe Johnson Drive, Knoxville, TN, 37996, USA.
Aaron G VincentDepartment of Plant Sciences, University of Tennessee, 301 Ag & Natural Resources Bldg., 2431 Joe Johnson Drive, Knoxville, TN, 37996, USA.
Ashley D Wise-MitchellCenter for Agricultural Synthetic Biology (CASB), University of Tennessee, 2640 Morgan Circle Dr., Knoxville, TN, 37996, USA.
C Neal StewartDepartment of Plant Sciences, University of Tennessee, 301 Ag & Natural Resources Bldg., 2431 Joe Johnson Drive, Knoxville, TN, 37996, USA.
Scott C LenaghanCenter for Agricultural Synthetic Biology (CASB), University of Tennessee, 2640 Morgan Circle Dr., Knoxville, TN, 37996, USA. slenagha@utk.edu.ORCID http://orcid.org/0000-0002-7539-1726

Funding

National Institute of Food and Agriculture 2022-33522-38289
6 · The paper itself

Abstract

key messageThis study describes an optimized plastid genetic engineering platform to produce full marker-free transplastomic plants with transgene integrated at homoplasmy in one step in tissue culture. Plastid engineering is attractive for both biotechnology and crop improvement due to natural bio-confinement from maternal inheritance, the absence of transgene positional effects and silencing, the ability to express transgenes in operons, and unparalleled production of heterologous proteins. While plastid engineering has had numerous successes in the production of high-value compounds, no transplastomic plants have been approved for use in agriculture. In order for transplastomic plants to be used in agriculture, the removal of antibiotic selection genes is required. In this work, we developed an optimized strategy to generate homoplasmic marker-free lines of potato (Solanum tuberosum) in a single transformation event. To achieve marker-free transplastomic lines, vectors were redesigned to enable integration of the transgene cassette into the plastid genome, while maintaining the selection cassette on the vector backbone. After an initial round of tissue culture with selection, the selective pressure was removed, leading to the elimination of the vector backbone, while retaining the integrated transgene cassette at homoplasmy. Marker-free transplastomic lines produced using this strategy had a normal phenotype, and transgene integration was stable across generations. The new vectors developed in this work for the generation of marker-free transplastomics will represent a valuable alternative platform for routine plastid genetic engineering in higher plants. It is also anticipated that this approach will contribute to speed the path to commercialization of these novel transplastomic plant varieties.

Indexed as

Genetic EngineeringGenome, ChloroplastPlants, Genetically ModifiedSolanum tuberosumTransgenesChloroplastsGenetic MarkersGenetic VectorsTransformation, GeneticGenetic MarkersBiosafetyMarker-free transplastomic plantsMini-synplastomePlastid engineeringSolanum tuberosum

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.